MAUDE Adverse Event Report: AMO MANUFACTURING USA, LLC IFS ADVANCED FEMTOSEC LASER; POWERED LASER SURGICAL INSTRUMENT

Model Number	J20007D
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Visual Disturbances (2140)
Date of Event	07/11/2024
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Section a2 a3, a4 and a5: unknown/ not provided.Section d6a: if implanted, give date: not applicable, as product is not an implantable device.Section d6b: if explanted, give date: not applicable, as product is not an implantable device.Device evaluation: remote support confirmed that the system is performing as intended.Product evaluation: field service engineer (fse) was onsite and performed a system evaluation for this incident.Fse determined that the device failed to function as intended.Pre-expander was replaced due to component failure.The complaint issue was confirmed, and it was attributed to the pre-expander component failure.Manufacturing records review: the manufacturing records for the device were reviewed.The product was manufactured and released according to specification.A search of complaints related to this serial number was performed.The search revealed 7 additional complaint folder was received for this complaint type.No escalations are required.Conclusion: as a result of the investigation, it was determined that the issue was due to a component failure.Part was replaced, and the system is performing as intended.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
Event or Problem Description
Customer reported a case of transient light sensitivity syndrome on a patient.Customer typically have their post-op patient use pred-moxi qid for 1 week, and then stop.For cases of tlss, the customer prescribe them on a taper regimen of pred-acetate 1%.All patients are doing good now.Pre-surgery best corrected visual acuity (bcva): 20/15.Bcva and uncorrected visual acuity va follow up surgery: bcva: 20/20 ucva: 20/25.Lasik performed right eye (od) only, so, od affected.Patient started noticing symptoms on 7/1, but called the office on 7/10.Customer saw patient on 7/11.Pt is scheduled for a follow up appointment on 7/24 for a post-op once steroid regimen is done.Pt knows to call back before 7/24 if there is no improvement or if things get worse.The surgeon verified that they all resolved within a couple days of starting the steroid drop regimen per follow up.
Additional Manufacturer Narrative
Additional information: on (b)(6) 2024, the clinical application specialist (cas) attended surgical cases and gelled the laser.Prior to cases, cas gelled the laser and received 80% melt at 1.10uj at 7/7 spot and line.The staff confirmed there were no complaints of tlss from the last surgical day.Max energy prior to all cases remained constant at 2.28uj.Bed and side cut energies were unchanged from 1.00uj bed energy, and 0.90uj side cut energy with a 7/7 spot and line.In cas speaking with dr.Richard maw, it was agreed to lower the bed energy slightly to 0.95uj.This was made the default.13 total lasik cases.Correction: upon further review on (b)(6) 2024, it was noted that information was inadvertently omitted from the initial report.Therefore, the missing information is captured in this supplemental report.On (b)(6) 2024, our clinical application specialist (cas) attended surgical cases and gelled the laser before, in the middle, and end of cases.Cas was at the site in response to prior complaints of tlss.Max energy prior to all cases varied between 2.27uj and 2.28uj.Bed and side cut energies were unchanged from 1.00uj bed energy and 0.90uj side cut energy with a 7/7 spot and line.Prior to cases, cas gelled the laser and received 80% melt at 1.20uj.In the middle of cases over the lunch break, cas gelled it at roughly 1.12uj with 80% melt.At the end of the day, the reading was still at roughly 1/12uj with 80% melt.All pertinent information available to johnson & johnson surgical vision, inc has been submitted.

• Brand Name: IFS ADVANCED FEMTOSEC LASER
• Common Device Name: POWERED LASER SURGICAL INSTRUMENT
• Manufacturer (Section D): AMO MANUFACTURING USA, LLC; 510 cottonwood drive; milpitas CA 95035
• Manufacturer Contact: somyata nagpal ; 31 technology drive; irvine, CA 92618 ; 7142478552
• MDR Report Key: 19940417
• Report Number: 3012236936-2024-000221
• Device Sequence Number: 15288747
• Product Code: GEX
• UDI-Device Identifier: 05050474573468
• UDI-Public: (01)05050474573468
• Combination Product (Y/N): N
• Initial Reporter State: IA
• Initial Reporter Country: US
• PMA/510(K) Number: K141852
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 08/28/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: J20007D
• Device Catalogue Number: J20007D
• Was Device Available for Evaluation?: Yes
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 07/12/2024
• Supplement Date Received by Manufacturer: 08/08/2024
• Initial Report FDA Received Date: 08/08/2024
• Supplement Report FDA Received Date: 08/28/2024
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 08/12/2019
• Is the Device Labeled for Single Use? (Y/N): No
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Reuse
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 42 YR
• Patient Sex: Male
• Patient Ethnicity: Non Hispanic
• Patient Race: White